These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8112965)

  • 41. Inhibition of intraocular proliferations with intravitreal corticosteroids.
    Tano Y; Sugita G; Abrams G; Machemer R
    Am J Ophthalmol; 1980 Jan; 89(1):131-6. PubMed ID: 6153251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy.
    Fastenberg DM; Diddie KR; Delmage JM; Dorey K
    Am J Ophthalmol; 1983 May; 95(5):663-7. PubMed ID: 6846457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
    Weller M; Heimann K; Wiedemann P
    Med Hypotheses; 1990 Feb; 31(2):157-9. PubMed ID: 2325589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of injections of cultured fibroblasts into the rabbit vitreous.
    Hitchins CA; Grierson I; Hiscott PS
    Graefes Arch Clin Exp Ophthalmol; 1985; 223(5):237-49. PubMed ID: 4065590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of different cellular inocula in an experimental model of massive periretinal proliferation.
    Fastenberg DM; Diddie KR; Sorgente N; Ryan SJ
    Am J Ophthalmol; 1982 May; 93(5):559-64. PubMed ID: 7081354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye.
    Hida T; Chandler DB; Sheta SM
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(4):303-7. PubMed ID: 3653728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy.
    Kirmani M; Santana M; Sorgente N; Wiedemann P; Ryan SJ
    Retina; 1983; 3(4):269-72. PubMed ID: 6201971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.
    Tano Y; Chandler D; Machemer R
    Am J Ophthalmol; 1980 Dec; 90(6):810-6. PubMed ID: 7446668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of 3,3'-iminodipropionitrile on experimental intravitreal proliferation in albino rabbits.
    Akiyama K
    Jpn J Ophthalmol; 1990; 34(4):401-8. PubMed ID: 2082060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Taxol treatment of experimental proliferative vitreoretinopathy.
    Daniels SA; Coonley KG; Yoshizumi MO
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):513-6. PubMed ID: 1979953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifibrotic and uveitogenic properties of gamma interferon in the rabbit eye.
    Hjelmeland LM; Li JW; Toth CA; Landers MB
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(1):84-90. PubMed ID: 1547974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
    Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy.
    La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F
    Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localised gamma irradiation and experimental intraocular proliferation.
    Chakravarthy U; Gardiner TA; Maguire CJ; Archer DB
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():792-9. PubMed ID: 3868220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of new retinal tears associated with the development of postoperative proliferative vitreoretinopathy.
    Fleury J; Bonnet M
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(5):459-62. PubMed ID: 1521814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intraocular fibrosis after perforating injury of the posterior segment. Experimental study].
    Kantelip B; Bacin F
    J Fr Ophtalmol; 1985; 8(3):245-53. PubMed ID: 4056316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
    Yoshimura N; Kuriyama S; Ohuchi T; Takemura M; Honda Y; Hiraoka M
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):404-9. PubMed ID: 1740372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silicone oil implantation in penetrating injuries complicated by PVR. Results from 1982 to 1986.
    Skorpik C; Menapace R; Gnad HD; Paroussis P
    Retina; 1989; 9(1):8-14. PubMed ID: 2717807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental model of proliferative vitreoretinopathy (PVR) in the vitrectomised eye: effect of silicone oil.
    Lean JS; van der Zee WA; Ryan SJ
    Br J Ophthalmol; 1984 May; 68(5):332-5. PubMed ID: 6712912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.